T 2312/18 of 20.07.2020

European Case Law Identifier: ECLI:EP:BA:2020:T231218.20200720
Date of decision: 20 July 2020
Case number: T 2312/18
Petition for review of: -
Application number: 07774640.2
IPC class: A61P 1/08 C07D 471/10 A61K 31/438
Language of proceedings: English
Distribution: No distribution (D)
Download: Decision in English
OJ versions: No OJ links found
Other decisions for this case: -
Abstracts for this decision: -
Application title: HYDROCHLORIDE SALT OF 8-[{1-(3,5-BIS-(TRIFLUOROMETHYL) PHENYL) -ETHOXY}-METHYL]-8-PHENYL-1,7-DIAZA-SPIRO[4.5]DECAN-2-ONE AND PREPARATION PROCESS THEREFOR
Applicant name: OPKO Health, Inc.
Opponent name: Teva Pharmaceutical Industries Ltd
Board: 3.3.02
Headnote: -
Relevant legal provisions: European Patent Convention Art 101 (2007)European Patent Convention Art 113(2) (2007)
Keywords: Basis of decision - text or agreement to text withdrawn by patent proprietor
Basis of decision - patent revoked
Catchword: -
Cited cases: T 0073/84 T 0655/11 T 0220/12 T 0381/12 T 2680/17
Citing cases: -

Order

For these reasons it is decided that:

1. The decision under appeal is set aside.

2. The patent is revoked.